Purchase Order 75N95023P00483
Award Date 8/7/23
Potential Completion Date 2/29/24
Potential Value $39K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lawrence, KS 66045, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The University of Kansas Center for Research, Inc. was awarded a $24,000 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to conduct feasibility testing for a topically applied formulation for rodent testing of bacterial elongation factor inhibitors. The testing will support the agency's efforts to develop new antibiotics by evaluating delivery methods for candidate compounds. No subcontractors or set aside designations...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed-price purchase order valued at $19,500 to the University of Kansas Center for Research, Inc. to conduct abbreviated testing for the feasibility of developing a solid dosage form for Metarrestin. The solicitation requested the vendor modify existing potency and impurity assays, evaluate physicochemical properties, conduct feasibility studies for...
- This federal contract award, valued at $10,900.00, was issued by the National Center for Advancing Translational Sciences, a civilian agency, to the University of Kansas Center for Research Inc., a non-profit research organization. The contract is a firm fixed-price purchase order with a completion date of July 21, 2026. The purpose is to prepare an amorphous solid dispersion (ASD) formulation of the compound TRND00658394 for use in animal efficacy studies. This contract is not associated with a...
- This $23,800.00 firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian federal agency, to the University of Kansas Center for Research Inc. on September 12, 2024. The contract is for preliminary solid dosage form development strategy of an ALDH1A1 inhibitor drug candidate for NCATS' Extramural Research and Training Branch (ETB). This contract does not have a set-aside designation. The University of Kansas Center for Research...
- This firm fixed-price purchase order for $22,500 was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to the University of Kansas Center for Research Inc. to conduct feasibility testing for solid dosage form strategy options for GPR110 agonist A8. The prime contractor will perform spray drying and adsorption techniques to generate powders from drug-polymer mixtures, emulsions, and suspensions with various...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to the University of Kansas Center for Research Inc., a non-profit subsidiary of the University of Kansas. The $7,070.00 firm fixed-price purchase order is for laboratory equipment and supplies, with a completion date of December 27, 2013. The award does not have a set-aside designation. The University of Kansas Center for Research Inc. frequently...
- The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a firm fixed-price purchase order valued at $22,500 to the University of Kansas Center for Research, Inc. This award is pursuant to a request for quote to develop a manufacturable tablet formulation of the compound NCGC72 for use in dog sarcoma clinical studies. The prime contractor will non-GMP manufacture 1,500 tablets total, with 1,000 tablets at 50mg dosage and 500 tablets at...
- This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) to the University of Kansas Center for Research Inc., a non-profit subsidiary of the University of Kansas. The $20,000.00 contract supports structural studies of cofactor-independent phosphoglycerate mutases (iPGMs), which are enzymes involved in glycolysis. As the prime contractor, the University of Kansas Center for Research Inc. will perform this research. The award does not have a set-aside...
- This is a firm-fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Altasciences Clinical Kansas Inc., a for-profit contract research organization (CRO) located in Overland Park, Kansas. The contract is for a study to evaluate the safety, tolerability, and pharmacokinetics of an investigational agent. The period of performance is from September 3, 2024, to March 11, 2026, with a ceiling value of $1,724,198.59. The contract...
- The National Institute on Drug Abuse issued a $1,838,614.86 delivery order to Altasciences Clinical Kansas Inc. on September 25, 2023, for pharmacokinetic and pharmacodynamic trials supporting Phase 1 cocaine drug interaction studies in medication development for substance use disorders. The order runs through October 22, 2025. Place of performance is Shawnee Mission, Kansas. The delivery order is priced on a firm fixed-price basis and was issued under a $21 million single-award indefinite...